QUIDELORTHO CORP Interest Income (Expense), Net
QUIDELORTHO CORP (QDEL) reported Interest Income (Expense), Net of -$163.50 million for the 12-month period ending 2024-12-29, per its 10-K filed 2025-02-27.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2025-02-27
- QUIDELORTHO CORP interest income (expense), net for the quarter ending 2024-12-29 was -$40.60M.
- QUIDELORTHO CORP interest income (expense), net for the quarter ending 2024-09-29 was -$42.90M.
- QUIDELORTHO CORP interest income (expense), net for the quarter ending 2024-06-30 was -$41.00M.
- QUIDELORTHO CORP interest income (expense), net for the quarter ending 2024-03-31 was -$39.00M.
- QUIDELORTHO CORP interest income (expense), net for fiscal 2024 was -$163.50M.
- QUIDELORTHO CORP interest income (expense), net for fiscal 2023 was -$147.60M.
- QUIDELORTHO CORP interest income (expense), net for fiscal 2023 was -$75.70M.
- QUIDELORTHO CORP interest income (expense), net for fiscal 2022 was -$5.80M.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2024-12-29 | -$40.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$83.50M derived: sum of 2 quarters · filed 2025-02-27 | -$124.50M derived: sum of 3 quarters · filed 2025-02-27 | -$163.50M 10-K · filed 2025-02-27 |
| 2024-09-29 | -$42.90M 10-Q · filed 2024-11-08 | -$83.90M derived: sum of 2 quarters · filed 2024-11-08 | -$122.90M 10-Q · filed 2024-11-08 | -$159.60M derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-06-30 | -$41.00M 10-Q · filed 2024-08-01 | -$80.00M 10-Q · filed 2024-08-01 | -$116.70M derived: sum of 3 quarters · filed 2025-02-27 | -$154.40M derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-03-31 | -$39.00M 10-Q · filed 2024-05-09 | -$75.70M derived: sum of 2 quarters · filed 2025-02-27 | -$113.40M derived: sum of 3 quarters · filed 2025-02-27 | -$149.90M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-12-31 | -$36.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$74.40M derived: sum of 2 quarters · filed 2025-02-27 | -$110.90M derived: sum of 3 quarters · filed 2025-02-27 | -$147.60M 10-K · filed 2025-02-27 |
| 2023-10-01 | -$37.70M 10-Q · filed 2024-11-08 | -$74.20M derived: sum of 2 quarters · filed 2024-11-08 | -$110.90M 10-Q · filed 2024-11-08 | -$145.60M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | -$36.50M 10-Q · filed 2024-08-01 | -$73.20M 10-Q · filed 2024-08-01 | -$107.90M derived: sum of 3 quarters · filed 2025-02-27 | -$137.60M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | -$36.70M 10-Q · filed 2024-05-09 | -$71.40M derived: sum of 2 quarters · filed 2025-02-27 | -$101.10M derived: sum of 3 quarters · filed 2025-02-27 | -$111.40M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | -$34.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$64.40M derived: sum of 2 quarters · filed 2025-02-27 | -$74.70M derived: sum of 3 quarters · filed 2025-02-27 | -$75.70M 10-K · filed 2025-02-27 |
| 2022-10-02 | -$29.70M 10-Q · filed 2023-11-02 | -$40.00M derived: sum of 2 quarters · filed 2023-11-02 | -$41.00M 10-Q · filed 2023-11-02 | -$42.10M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | -$10.30M 10-Q · filed 2023-08-09 | -$11.30M 10-Q · filed 2023-08-09 | -$12.40M derived: sum of 3 quarters · filed 2024-08-01 | -$13.70M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | -$1.00M 10-Q · filed 2023-05-04 | -$2.10M derived: sum of 2 quarters · filed 2024-08-01 | -$3.40M derived: sum of 3 quarters · filed 2024-08-01 | -$4.80M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-01-02 | -$1.10M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | -$2.40M derived: sum of 2 quarters · filed 2024-08-01 | -$3.80M derived: sum of 3 quarters · filed 2024-08-01 | -$5.80M 10-K/A · filed 2024-08-01 |
| 2021-10-03 | -$1.30M 10-Q · filed 2022-11-04 | -$2.70M derived: sum of 2 quarters · filed 2022-11-04 | -$4.70M 10-Q · filed 2022-11-04 | |
| 2021-07-04 | -$1.40M 10-Q · filed 2022-08-05 | -$3.40M 10-Q · filed 2022-08-05 | ||
| 2021-01-03 | -$8.50M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |